WO1989012653A1 - Segmented polyether polyurethane - Google Patents

Segmented polyether polyurethane Download PDF

Info

Publication number
WO1989012653A1
WO1989012653A1 PCT/US1989/002618 US8902618W WO8912653A1 WO 1989012653 A1 WO1989012653 A1 WO 1989012653A1 US 8902618 W US8902618 W US 8902618W WO 8912653 A1 WO8912653 A1 WO 8912653A1
Authority
WO
WIPO (PCT)
Prior art keywords
urea
polyether polyurethane
glycol
polyurethane
molecular weight
Prior art date
Application number
PCT/US1989/002618
Other languages
French (fr)
Inventor
Andrew M. Reed
Ian N. Askill
Willis W. Weber
Original Assignee
Matrix Medica, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Medica, Inc. filed Critical Matrix Medica, Inc.
Priority to JP1507147A priority Critical patent/JP3065629B2/en
Publication of WO1989012653A1 publication Critical patent/WO1989012653A1/en
Priority to FI900800A priority patent/FI900800A0/en
Priority to NO90900764A priority patent/NO900764L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72Polyisocyanates or polyisothiocyanates
    • C08G18/74Polyisocyanates or polyisothiocyanates cyclic
    • C08G18/76Polyisocyanates or polyisothiocyanates cyclic aromatic
    • C08G18/7657Polyisocyanates or polyisothiocyanates cyclic aromatic containing two or more aromatic rings
    • C08G18/7664Polyisocyanates or polyisothiocyanates cyclic aromatic containing two or more aromatic rings containing alkylene polyphenyl groups
    • C08G18/7671Polyisocyanates or polyisothiocyanates cyclic aromatic containing two or more aromatic rings containing alkylene polyphenyl groups containing only one alkylene bisphenyl group
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08Processes
    • C08G18/10Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
    • C08G18/12Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step using two or more compounds having active hydrogen in the first polymerisation step
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/48Polyethers
    • C08G18/4804Two or more polyethers of different physical or chemical nature
    • C08G18/4808Mixtures of two or more polyetherdiols

Definitions

  • This invention relates to a segmented polyether polyurethane-urea resin having certain controlled physical properties, and in particular to a segmented polyether polyurethane-urea resin that exhibits an increase in tensile strength and elongation when wet with water and that can be formed into a visually clear film that is permeable to water vapor and is hydrophilic.
  • Segmented polyurethanes are prepared from hydroxyl terminated low molecular weight polyethers or polyesters or mixtures thereof by reacting these materials with a stoichiornetric excess of a diisocyanate to produce an isocyanate terminated prepolymer. This reactive prepolymer is then chain extended with a difunctional compound containing an active hydrogen such as water, glycols, aminoalcohols or diamines.
  • Diamine-extended polyurethanes have a relatively high urea linkage content due to their diamine extension.
  • This high urea linkage content results in relatively high levels of hydrogen bonding which, in turn, produces strong elastic materials with good flex life properties.
  • this high level of hydrogen bonding renders the polyurethane non-thermoplastic.
  • This non-thermoplastic nature severely restricts the processes which may be utilized to fabricate these polyurethanes into useful devices. Techniques such as extrusion, injection molding and heat sealing cannot be utilized due to the polyurethanes' inability to melt and flow prior to decomposition. Segmented polyurethanes have also been synthesized utilizing relatively low molecular weight diols as chain extension agents.
  • diols produce a segmented polyurethane having reduced levels of hydrogen bonding.
  • these particular polyurethanes have reduced physical properties such as elongation, ultimate tensile strength and flex life as compared to their equivalent diamine extended counterparts.
  • this relatively lower level of hydrogen bonding renders the polyurethane thermoplastic and allows it to be extruded , injection molded, heat sealed, etc.
  • segmented polyurethane block copolymers arise from a two phase microstructure. This two phase structure is derived from the individual chain structure of the polyurethane. Segmented polyurethane polymer chains may be considered as a series of alternating "soft" and “hard” blocks. Typically, the "soft" blocks are diisocyanate-coupled relatively low melting point polyester or polyether polymers of relatively low molecular weight.
  • the "hard” blocks include single diurethane linkages resulting when a diisocyanate molecule couples two polyester or polyether molecules. More particularly, they are the relatively higher melting urethane or urea chain segments formed by the reaction of diisocyanate with a glycol and/or a diamine chain extender.
  • Portions of "hard” blocks form discernible crystalline domains while portions of the “soft” blocks form the basis for an amorphous polymer matrix.
  • U.S. Patent No. 3,635,907 to Schulze, et al. discloses a polyurethane wherein a mixture of chain extenders such as diamines, hydrazine, or hydrazine derivatives, and aminoalcohols is utilized for chain extension, followed by further addition of a diisocyanate and a diol.
  • the ultimate tensile strength of the polyurethane is varied by varying the quantity of diisocyanate added (column 4, lines 8-11).
  • the reaction between the chain extenders and the NCO-groups of the prepolymer is terminated by the addition of aliphatic alcohols (column 1, lines 70-72).
  • Films produced from polyurethanes derived from linear polyesters admixed with relatively low molecular weight aliphatic diols are said to be non-porous and impermeable to water vapor (column 2, lines 27-28).
  • the present invention provides segmented polyether polyurethane-urea resins which have superior physical properties such as an increase in strength when wet with water, elongation, ultimate tensile strength, and flex life. Some of the present resins may be readily extruded, injection molded and heat sealed, and can be made into visually clear films that are hydrophilic and are permeable to water vapor. Such films are eminently well suited for the fabrication of wound dressings.
  • the present invention contemplates a hydrophilic, segmented polyether polyurethane-urea that exhibits an increase in tensile strength and elongation when wet with water, and that is capable of forming a visually clear film.
  • films embodying this invention exhibit a moisture vapor transport rate several orders of magnitude higher than that of silicone-derived films.
  • This polyurethane-urea is a reaction product of a diisocyanate-polyalkylene ether glycol mixture prepolymer chain extended with a difunctional amine chain extender such as an aliphatic diamine and/or an alkanolamine.
  • segmented polyurethane-urea resins of the present invention are derived from a prepolymer formed from a diisocyanate reacted with a certain mixture of polyalkylene ether glycols to form an isocyanate-terminated prepolymer.
  • the polyalkylene ether glycols selected for the mixture have repeating alkyleneoxy segments of unequal lengths. That is, a polyalkylene ether glycol having relatively longer alkyleneoxy segments is mixed with at least one other polyalkylene ether glycol having relatively shorter alkyleneoxy segments.
  • This prepolymer is then chain extended to a desired, relatively higher, number average molecular weight, usually in the range of about 20,000 to about 260,000, by reaction with an admixture of at least one difunctional chain extender, such as an aliphatic diamine, and preferably admixed with at least one chain control agent such as a monofunctional amine.
  • a polymeric wetting agent such as polyvinylpyrrolidone or the like is also present.
  • Control of the hydrophilicity of the present polyurethane-urea resins can be done intrinsically by selecting a desired mixture of polyalkylene ether glycols and by adjusting the ratio of these polyalkylene ether glycols as the prepolymer of the resin is made.
  • Hydrophilicity of the resin can also be controlled extrinsically by incorporation into the prepared resin of a hydrophilic polymer that is soluble in the segmented polyurethane resin, e.g., polyvinylpyrrolidone. As the degree of hydrophilicity is varied, the rate of moisture transport and vapor permeability through the present polyurethanes are also varied.
  • the present polyurethane-urea resins can be processed into porous films or membranes, if desired, in accordance with practices taught in U.S. Patent No. 4,704,130 to Gilding et al.
  • porous films have utility as membranes for various separation processes, for wound dressings, and the like.
  • FIGURES 1 through 15 are graphical representations showing constant dry tensile strength - wet tensile strength differential contours (expressed in kilograms per square millimeter) derived from a multiple regression model of experimental data.
  • the "soft" block of the resins of the present invention is ideally a relatively low melting point polyether of low molecular weight.
  • the "hard” block is ideally formed from the diurethane linkages resulting from the reaction of two polyether molecules and the urethane/urea segments formed from the reaction of diisocyanate and/or an alkanolamine and a diamine.
  • the stoichiometry of the polyurethane-ureas of the present invention is such that the "soft” blocks are of relatively greater block length than the corresponding "hard” blocks.
  • the "hard” blocks can be better characterized as "hard” units as they are present in limited numbers and are of relatively short block length. This situation ensures that little true crystallization of the "hard” block can take place.
  • Crystallization of the "soft" block is possible, but produces less rigid crystallites than those potentially formed from the “hard” blocks.
  • the stoichiometry of the diamines and alkanolamines used in the chain extension of these polyurethane-ureas allows adjustment of the degree and distribution of hydrogen bonding in the produced polymers.
  • polyurethane-ureas of the present invention While encompassing traditional theories, depart, however, from the currently held views regarding phase separation, hydrogen bonding, etc. This departure can be seen clearly in the current polyurethane-urea's mechanical properties after equilibration in a series of organic and aqueous solutions as will be described in greater detail hereinbelow.
  • polyurethane-ureas of the present invention increase in tensile strength and elongation when wet with water. While not wishing to be bound by a particular theory, it is believed that the polymers of the present invention behave as follows. Water, being a small, highly polar molecule, is known to participate in "bridging" reactions with various chemical groupings through its hydrogen atom. In the case of the polyurethanes of the present invention, the hydrogen atoms in the water molecules participate in a "bridging" reaction between oxygen atoms in the polyether "soft" block segments. The "soft" blocks are considered to be coiled and the hydrogen
  • bridging takes place both between oxygen contained in adjacent loops of the mixed polyether coil and between oxygen present in other surrounding coils (either in the same polymer chain or a second chain). The “bridging” increases the strength of the respective chain which is observed as an increase in mechanical strength of the polymer.
  • the present segmented polyurethane-urea resins are the reaction products of certain isocyanate-terminated prepolymers with certain amounts of chain extenders or chain extender mixtures.
  • the aforementioned prepolymers are the products of the reaction of a stoichiometric excess of a diisocyanate with an admixture of polyalkylene ether glycols having repeating alkyleneoxy groups of different size, i.e., the length of repeating alkylene units is different in each of the glycols.
  • the preferred mol ratio of diisocyanate-to-polyalkylene ether glycol mixture is about 3:2.
  • the prepolymer contains no residual hydroxyl groups.
  • organic diisocyanates may be utilized for present purposes, including aromatic, aliphatic and cycloaliphatic diisocyanates and combinations thereof.
  • Representative diisocyanates include toluene diisocyanate (TDI), diphenylmethylene diisocyanate (MDI), hexamethylene diisocyanate, cyclohexylene diisocyanate, methylene dicyclohexane diisocyanate, 2,2,4-trimethyl hexamethylene diisocyanate.
  • isophorone diisocyanate isophorone diisocyanate, m-phenylene diisocyanate, 4-chloro-1, 3-phenylene diisocyanate, 4, 4'-biphenylene diisocyanate, 1, 5-naphthylene diisocyanate, 1,4-tetramethylene diisocyanate, 1,6-hexamethylene diisocyanate, 1,10-decamethylene diisocyanate and 1,4-cyclohexylene diisocyanate.
  • the preferred diisocyanates are aromatic in nature, e.g., TDI, MDI, and the like.
  • the polyalkylene ether glycols that constitute an admixture suitable for the present purposes are chosen so that the repeating alkyleneoxy segments in each of the glycols is of a different size.
  • the polyalkylene ether glycol having the relatively shorter alkyleneoxy segments preferably has a number average molecular weight in the range of about 1,000 to about 3,000.
  • the polyalkylene ether glycol having the relatively longer alkyleneoxy segments has a number average molecular weight of at least about 800, and the molecular weight can be as high as about 4,000.
  • the polyalkylene ether glycols that constitute the admixture have substantially the same number average molecular weight, more preferably a number average molecular weight of about 2,000.
  • the polyalkylene ether glycol having the relatively shorter alkyleneoxy segments constitutes at least about 10 mole percent of the admixture, and the polyalkylene ether glycol having the relatively longer alkyleneoxy segments constitutes a major portion of the admixture, i.e., more than about 50 mole percent of the glycol admixture.
  • Particularly preferred are polyalkylene ether glycol admixtures containing about 25 mole percent of the glycol having the relatively shorter alkyleneoxy segments and about 75 mole percent of the glycol having the relatively longer alkyleneoxy segments.
  • polyalkylene ether glycol admixtures useful in the formation of the prepolymer are polyethylene glycol with polytetramethylene glycol, polypropylene glycol with 1,2-polydimethylethylene glycol, polydecamethylene glycol with polyethylene glycol, and the like.
  • a preferred polyalkylene ether glycol admixture is that of polytetramethylene glycol and polyethylene glycol.
  • a preferred combination is polytetramethylene glycol (PTMEG) having a number average molecular weight of about 2,000 and polyethylene glycol (PEG) having a number average molecular weight of about 2,000 in a mole ratio of about 1:1 to about 3:1, respectively, for an optimum degree of hydrophilicity in combination with a desired degree of hydrogen bonding in the produced film.
  • PTMEG polytetramethylene glycol
  • PEG polyethylene glycol
  • the formation of the isocyanate terminated prepolymer occurs in a liquid state and at a temperature of about 50 to about 100°C, preferably at about 80 to about 85°C.
  • the reaction time is about 1 to about 1-1/2 hours.
  • a suitable solvent such as dimethylacetamide (DMAC) , dimethylformamide (DMF), tetrahydrofuran (THF), or the like.
  • DMAC dimethylacetamide
  • DMF dimethylformamide
  • THF tetrahydrofuran
  • the prepolymer is chain extended to the desired number average molecular weight, usually in the range of about 20,000 to about 260,000, using a difunctional chain extender, preferably an admixture of such chain extenders.
  • a difunctional chain extender preferably an admixture of such chain extenders.
  • the chain extender admixture at least one chain extender is an aliphatic diamine and at least one other chain extender is an alkanolamine.
  • Suitable aliphatic diamine chain extenders include ethylene diamine, m-xylylene diamine, propylene diamine, and the like.
  • Suitable alkanolamine chain extenders include ethanolamine, and the like.
  • Other chain extenders such as diols can also be present.
  • a preferred combination of chain extenders is ethylene diamine with ethanolamine. The mol ratio of ethylene diamine to ethanolamine can be about 0.25:0.75 to about 0.75:0.25.
  • a preferred monofunctional amine chain control agent includes at least one member of the group consisting of 3,3-dimethylbutylamine, dimethylcyclohexylamine, 1,5-dimethylhexylamine, and dimethylethylene diamine.
  • the amount of the chain control agent is dependent on the amount of NCO-groups present in the prepolymer and the desired chain extension. In any particular case, sufficient chain control agent is added to react with the remaining NCO-groups present after the desired degree of chain extension has been achieved.
  • the chain extender and chain control agent are dissolved in a suitable solvent such as DMAC, DMF, THF, etc. as mentioned hereinabove.
  • the prepolymer is then reacted with the chain extender and chain control agent solution to obtain the desired chain extension of the prepolymer.
  • This reaction is usually carried out at a temperature of about 80 to about 85°C. over a time period of about 2 to about 3-1/2 hours.
  • a polyurethane-urea resin solution is thus produced.
  • the hydrophilicity of the polyurethane resin may be enhanced by the use of an extrinsic wetting agent such as polyvinylpyrrolidone or the like, which is added to the polymerized resin prior to film forming.
  • the amount of polyvinylpyrrolidone utilized for this purpose is about 1 to about 50 percent by weight of the composition.
  • polyurethane-ureas embodying the present invention.
  • the polyurethane-urea prepolymer was prepared in a suitable reactor vessel equipped with an agitator, a temperature sensor, a temperature control and a nitrogen source and bleed.
  • the chain extenders and chain control agents were admixed in a separate mixing vessel and the resulting admixture was then added to the reactor vessel.
  • Polytetramethylene glycol (M.W. 1000; 257.14 grams) and polyethylene glycol (M.W. 1000; 28.57 grams) were combined and melted at a temperature of approximately 40 to 45°C. in the reactor under a nitrogen blanket.
  • 4,4'-Diphenylmethane diisocyanate (117.86 grams) was added to the reactor under agitation. The resulting mixture was stirred, heated to a temperature of about 60 to 65°C. and maintained within this temperature range for a time period of about 1 to about 1-1/2 hours to produce a molten prepolymer.
  • Dry dimethylacetamide (DMAC; 857.59 grams) was then added to the molten prepolymer and the admixture was stirred until dissolution of the prepolymer was complete. This occurred in about 15 to about 30 minutes.
  • Polytetramethylene glycol (M.W. 1000; 214.29 grams) and polyethylene glycol (M.W. 1000; 71.43 grams) were combined and melted at a temperature of approximately 40 to 45°C. in the reactor under a nitrogen blanket.
  • 4,4'-Diphenylmethane diisocyanate (117.86 grams) was added to the reactor under agitation. The resulting mixture was stirred, heated to a temperature of about 60 to 65°C. and maintained within this temperature range for a time period of about 1 to about 1-1/2 hours.
  • Dry dimethylacetamide (DMAC; 857.59 grams) was then added to the molten prepolymer and the admixture was stirred until dissolution of the prepolymer was complete.
  • Polytetramethylene glycol (M.W. 1000; 71.43 grams) and polyethylene glycol (M.W. 1000; 214.29 grams) were combined and melted at approximately 40 to 45°C. in the reactor under a nitrogen blanket.
  • 4,4'-Diphenylmethane diisocyanate (117.86 grams) was added to the reactor under agitation. The resulting mixture was stirred, heated to a temperature of about 60 to 65°C. and maintained within this temperature range for a time period of about 1 to about 1-1/2 hours to produce a molten prepolymer.
  • Dry dimethylacetamide (DMAC; 857.61 grams) was then added to the molten prepolymer and the admixture was stirred until dissolution of the prepolymer was complete. This occurred in about 15 to about 30 minutes.
  • the resultant polyurethane resin solution was colorless and viscous, and was cast into a visually clear film.
  • the polyurethane resins of the present invention are particularly well suited for the manufacture of components for wound dressings and closures inasmuch as the high level of hydrophilicity, and therefore the absorption capacity, inherent in these polymers are important properties in this regard.
  • Environmental wound dressings rely upon being able to absorb wound exudate while maintaining a moist microenvironment at the wound site to obtain optimum healing.
  • the present polyurethane resins can be tailored to have properties, when cast into films, so as to absorb excess exudate while maintaining a high level of moisture at the wound site.
  • the chemical, physical and mechanical properties of the present polyurethanes allow their use in a wide variety of other applications.
  • the material's wet strength properties and selective permeability towards water vapor and other gases are particularly significant in this regard.
  • the present polymers may be coated onto textile substrates to provide breathability while retaining resistance to liquids, particularly water.
  • selectively permeable films may be fabricated for use as containers for desiccants and other absorbent agents (e.g., crystalline aluminosilicates, silica gel, etc.).
  • desiccants and other absorbent agents e.g., crystalline aluminosilicates, silica gel, etc.
  • the use of these films in this application has the advantage of preventing particulate contamination of the article into which the desiccant package will be placed and reduction of efficiency due to nonspecific absorption. Films of these materials are also suitable for packaging. Their selective gaseous and moisture vapor transmission properties allow their application in the area of environmental packaging.
  • polymers are biocompatible and noncytotoxic which makes them ideal for medical and biological applications. These properties enable the present polymers to be used as substrates for the support, growth and attachment of biological materials. They are of particular utility in the area of cell growth substrates for mammalian cell culture. The attachment and growth of cells to structures manufactured from these polymers makes them ideal for use in bioreactor systems for large scale production of cell lines, etc. Immobilization of proteins, enzymes and other biologically active materials, while maintaining biological activity, allows the use of these polymers as active structures in biosensors and diagnostic test kits. Similarly, nonbiologically active catalysts may be incorporated in these polymers, thereby facilitating their use in numerous chemical and physical processes.
  • Selective transport of chemical agents through polymer films fabricated from these polymers can be used in the areas of filtration, separation and purification of liquids and gases. These properties are also of use in the area of drug delivery over an extended time period where therapeutic agents are delivered from a reservoir across a polymer membrane into the physiological environment. It is also envisaged that these polymers may be used as specialty coatings to inhibit corrosion of metallic surfaces while facilitating selective gaseous transport.
  • the present segmented polyether polyurethane resins are also useful for the fabrication of vascular grafts, ureters and other biocompatible elements.

Abstract

A hydrophilic, segmented polyether polyurethane-urea that exhibits an increase in tensile strength and elongation when wet with water and is capable of forming visually clear films permeable to water vapor is disclosed.

Description

SEGMENTED POLYETHER POLYURETHANE
Description Technical Field This invention relates to a segmented polyether polyurethane-urea resin having certain controlled physical properties, and in particular to a segmented polyether polyurethane-urea resin that exhibits an increase in tensile strength and elongation when wet with water and that can be formed into a visually clear film that is permeable to water vapor and is hydrophilic. Background of the Invention
Segmented polyurethanes are prepared from hydroxyl terminated low molecular weight polyethers or polyesters or mixtures thereof by reacting these materials with a stoichiornetric excess of a diisocyanate to produce an isocyanate terminated prepolymer. This reactive prepolymer is then chain extended with a difunctional compound containing an active hydrogen such as water, glycols, aminoalcohols or diamines.
Diamine-extended polyurethanes have a relatively high urea linkage content due to their diamine extension. This high urea linkage content results in relatively high levels of hydrogen bonding which, in turn, produces strong elastic materials with good flex life properties. However, this high level of hydrogen bonding renders the polyurethane non-thermoplastic. This non-thermoplastic nature severely restricts the processes which may be utilized to fabricate these polyurethanes into useful devices. Techniques such as extrusion, injection molding and heat sealing cannot be utilized due to the polyurethanes' inability to melt and flow prior to decomposition. Segmented polyurethanes have also been synthesized utilizing relatively low molecular weight diols as chain extension agents. The use of diols produces a segmented polyurethane having reduced levels of hydrogen bonding. As a result of this reduction in hydrogen bonding, these particular polyurethanes have reduced physical properties such as elongation, ultimate tensile strength and flex life as compared to their equivalent diamine extended counterparts. However, this relatively lower level of hydrogen bonding renders the polyurethane thermoplastic and allows it to be extruded , injection molded, heat sealed, etc.
It is known that the mechanical properties and predominately the elastic properties of linear segmented polyurethane block copolymers arise from a two phase microstructure. This two phase structure is derived from the individual chain structure of the polyurethane. Segmented polyurethane polymer chains may be considered as a series of alternating "soft" and "hard" blocks. Typically, the "soft" blocks are diisocyanate-coupled relatively low melting point polyester or polyether polymers of relatively low molecular weight. The "hard" blocks include single diurethane linkages resulting when a diisocyanate molecule couples two polyester or polyether molecules. More particularly, they are the relatively higher melting urethane or urea chain segments formed by the reaction of diisocyanate with a glycol and/or a diamine chain extender.
The polar nature of the recurring rigid "hard" urethane/urea chain segments results in their strong mutual attraction. This attraction (both inter- and intra-molecular) leads to aggregation and ordering into crystalline and paracrystalline domains (also called pseudo crystalline domains) in a mobile polymer matrix. The high level of urethane and urea hydrogen atoms together with carbonyl and ether oxygen groups permits extensive hydrogen bonding in these systems. The level of this hydrogen bonding restricts the mobility of chain segments to organize extensively into crystalline lattices. The result is a polymer system in which there are at least three levels of association.
Portions of "hard" blocks form discernible crystalline domains while portions of the "soft" blocks form the basis for an amorphous polymer matrix. There is, however, at least a third "phase" which is formed from the complex interaction of paracrystallinity and hydrogen bonding. This leads to the formation of what has been described as "pseudo crosslinks". That is, primary polyurethane chains are crosslinked in effect, but not in fact. The overall consequence is the formation of a labile network of polymer chains which display many of the mechanical, chemical and physical properties of truly crosslinked networks. This type of "pseudo crosslinking" may be partially reversed or enhanced by heat and solvation.
Extrudable, water-extended polytetramethylene ether polyurethane-urea resins are described in U.S. Patent No. 4,062,834 to Gilding et al. The described resins have been rendered extrudable by a reduction and rearrangement of the hydrogen bonds in the polymer chain. This is accomplished by reacting the isocyanate terminated prepolymer with water to form an unstable carbamate which in turn decomposes to form an amine and carbon dioxide. The so formed amine terminated prepolymer is then reacted with another molecule of isocyanate terminated prepolymer. The polyurethanes thus produced prove to be thermoplastic; however, the physical properties such as elongation, ultimate tensile strength and flex life are inferior.
U.S. Patent No. 3,635,907 to Schulze, et al. discloses a polyurethane wherein a mixture of chain extenders such as diamines, hydrazine, or hydrazine derivatives, and aminoalcohols is utilized for chain extension, followed by further addition of a diisocyanate and a diol. The ultimate tensile strength of the polyurethane is varied by varying the quantity of diisocyanate added (column 4, lines 8-11). The reaction between the chain extenders and the NCO-groups of the prepolymer is terminated by the addition of aliphatic alcohols (column 1, lines 70-72). Films produced from polyurethanes derived from linear polyesters admixed with relatively low molecular weight aliphatic diols are said to be non-porous and impermeable to water vapor (column 2, lines 27-28).
The present invention provides segmented polyether polyurethane-urea resins which have superior physical properties such as an increase in strength when wet with water, elongation, ultimate tensile strength, and flex life. Some of the present resins may be readily extruded, injection molded and heat sealed, and can be made into visually clear films that are hydrophilic and are permeable to water vapor. Such films are eminently well suited for the fabrication of wound dressings. Summary of the Invention
The present invention contemplates a hydrophilic, segmented polyether polyurethane-urea that exhibits an increase in tensile strength and elongation when wet with water, and that is capable of forming a visually clear film. In addition, films embodying this invention exhibit a moisture vapor transport rate several orders of magnitude higher than that of silicone-derived films. This polyurethane-urea is a reaction product of a diisocyanate-polyalkylene ether glycol mixture prepolymer chain extended with a difunctional amine chain extender such as an aliphatic diamine and/or an alkanolamine.
More particularly, segmented polyurethane-urea resins of the present invention are derived from a prepolymer formed from a diisocyanate reacted with a certain mixture of polyalkylene ether glycols to form an isocyanate-terminated prepolymer. The polyalkylene ether glycols selected for the mixture have repeating alkyleneoxy segments of unequal lengths. That is, a polyalkylene ether glycol having relatively longer alkyleneoxy segments is mixed with at least one other polyalkylene ether glycol having relatively shorter alkyleneoxy segments. This prepolymer is then chain extended to a desired, relatively higher, number average molecular weight, usually in the range of about 20,000 to about 260,000, by reaction with an admixture of at least one difunctional chain extender, such as an aliphatic diamine, and preferably admixed with at least one chain control agent such as a monofunctional amine. Optionally, a polymeric wetting agent such as polyvinylpyrrolidone or the like is also present.
Control of the hydrophilicity of the present polyurethane-urea resins can be done intrinsically by selecting a desired mixture of polyalkylene ether glycols and by adjusting the ratio of these polyalkylene ether glycols as the prepolymer of the resin is made. Hydrophilicity of the resin can also be controlled extrinsically by incorporation into the prepared resin of a hydrophilic polymer that is soluble in the segmented polyurethane resin, e.g., polyvinylpyrrolidone. As the degree of hydrophilicity is varied, the rate of moisture transport and vapor permeability through the present polyurethanes are also varied. The present polyurethane-urea resins can be processed into porous films or membranes, if desired, in accordance with practices taught in U.S. Patent No. 4,704,130 to Gilding et al. Such porous films have utility as membranes for various separation processes, for wound dressings, and the like.
Numerous other advantages and features of the present invention will become readily apparent from the following detailed description of invention, the accompanying examples and the appended claims. Brief Description of Drawings In the drawings,
FIGURES 1 through 15 are graphical representations showing constant dry tensile strength - wet tensile strength differential contours (expressed in kilograms per square millimeter) derived from a multiple regression model of experimental data.
In FIGURES 1, 3, 5, 7, 9, 11, 13 and 15 all variables except the coordinate variables were held at their mean experimental values, and in FIGURES 2, 4, 6, 8, 10, 12 and 14 all variables except the coordinate variables were held at about their optimum values.
The mean experimental values were as follows: mole percent polyethylene glycol (PEG) 49.026 molecular weight of PEG 1426 molecular weight of polytetramethylene glycol (PTMEG) 1268.2 extension 23.776 mole fraction ethylene diamine (EDA) 0.49026
The optimum values were as follows: mole percent PEG 25 molecular weight of PEG 2000 molecular weight of PTMEG 2000 extension 40 mole fraction of EDA 0.5
Detailed Description of the Preferred Embodiments While this invention is susceptible to embodiment in many different forms, preferred embodiments of the invention are shown. It should be understood, however, that the present disclosure is to be considered as an exemplification of the principles of this invention and is not intended to limit the invention to the embodiments illustrated. In the present polyurethane-ureas the level of "pseudo crosslinking" and general phase separation present can be adjusted in a controllable, predictable fashion. This enables the physical and mechanical properties to be tailored to specific requirements. The modification of these materials has been accomplished by controlling the following parameters.
The "soft" block of the resins of the present invention is ideally a relatively low melting point polyether of low molecular weight. The "hard" block is ideally formed from the diurethane linkages resulting from the reaction of two polyether molecules and the urethane/urea segments formed from the reaction of diisocyanate and/or an alkanolamine and a diamine. The stoichiometry of the polyurethane-ureas of the present invention is such that the "soft" blocks are of relatively greater block length than the corresponding "hard" blocks. In fact, the "hard" blocks can be better characterized as "hard" units as they are present in limited numbers and are of relatively short block length. This situation ensures that little true crystallization of the "hard" block can take place. Crystallization of the "soft" block is possible, but produces less rigid crystallites than those potentially formed from the "hard" blocks. The stoichiometry of the diamines and alkanolamines used in the chain extension of these polyurethane-ureas allows adjustment of the degree and distribution of hydrogen bonding in the produced polymers.
The polyurethane-ureas of the present invention, while encompassing traditional theories, depart, however, from the currently held views regarding phase separation, hydrogen bonding, etc. This departure can be seen clearly in the current polyurethane-urea's mechanical properties after equilibration in a series of organic and aqueous solutions as will be described in greater detail hereinbelow.
As previously described, conventional polyurethanes obtain their mechanical properties from "pseudo crosslinks". These crosslinks are considered to be a function of the level of hydrogen bonding between the various polar groups present in the polymer's structure. The placement of these polar groups and, therefore, hydrogen bonds is accepted as being predominately in the "hard" blocks of the polymer (i.e., associated wth the urethane and urea linkages). Contributions to the strength of the material from the "soft" block portions are considered negligible by conventional theories. It would be expected, therefore, that an equilibration with a liquid which disrupts hydrogen bonds (e.g., water) would reduce the polymer's mechanical strength and elongation. However, such a reduction in mechanical strength and elongation for polyurethane-ureas of the present invention is not observed when these polyurethane-ureas are equilibrated with water. In fact, the contrary is found to be the case. The polyurethane-ureas of the present invention increase in tensile strength and elongation when wet with water. While not wishing to be bound by a particular theory, it is believed that the polymers of the present invention behave as follows. Water, being a small, highly polar molecule, is known to participate in "bridging" reactions with various chemical groupings through its hydrogen atom. In the case of the polyurethanes of the present invention, the hydrogen atoms in the water molecules participate in a "bridging" reaction between oxygen atoms in the polyether "soft" block segments. The "soft" blocks are considered to be coiled and the hydrogen
"bridging" takes place both between oxygen contained in adjacent loops of the mixed polyether coil and between oxygen present in other surrounding coils (either in the same polymer chain or a second chain). The "bridging" increases the strength of the respective chain which is observed as an increase in mechanical strength of the polymer.
The observed increase in elongation is believed to be due to the changing balance of the inter- to intra-molecular "bridging" that is present as the materials are placed under tensile stress. The stress also induces chain slippage which allows alignment and optimization of "bridging" and hydrogen bonding. When equilibrated with a liquid which is not capable of "bridging" (e.g., methanol) the polyurethane-ureas of the present invention do not show an increase in mechanical properties. As a matter of fact, decrease in tensile strength and elongation is observed as compared with dry samples of the same materials. The observed decrease is considered to be due to methanol' s effect on the balance of "pseudo crosslinking" and "pseudo crystallinity".
The present segmented polyurethane-urea resins are the reaction products of certain isocyanate-terminated prepolymers with certain amounts of chain extenders or chain extender mixtures. The aforementioned prepolymers, in turn, are the products of the reaction of a stoichiometric excess of a diisocyanate with an admixture of polyalkylene ether glycols having repeating alkyleneoxy groups of different size, i.e., the length of repeating alkylene units is different in each of the glycols. The preferred mol ratio of diisocyanate-to-polyalkylene ether glycol mixture is about 3:2. The prepolymer contains no residual hydroxyl groups.
Any of a wide variety of organic diisocyanates may be utilized for present purposes, including aromatic, aliphatic and cycloaliphatic diisocyanates and combinations thereof. Representative diisocyanates include toluene diisocyanate (TDI), diphenylmethylene diisocyanate (MDI), hexamethylene diisocyanate, cyclohexylene diisocyanate, methylene dicyclohexane diisocyanate, 2,2,4-trimethyl hexamethylene diisocyanate. isophorone diisocyanate, m-phenylene diisocyanate, 4-chloro-1, 3-phenylene diisocyanate, 4, 4'-biphenylene diisocyanate, 1, 5-naphthylene diisocyanate, 1,4-tetramethylene diisocyanate, 1,6-hexamethylene diisocyanate, 1,10-decamethylene diisocyanate and 1,4-cyclohexylene diisocyanate. The preferred diisocyanates are aromatic in nature, e.g., TDI, MDI, and the like.
The polyalkylene ether glycols that constitute an admixture suitable for the present purposes are chosen so that the repeating alkyleneoxy segments in each of the glycols is of a different size. The polyalkylene ether glycol having the relatively shorter alkyleneoxy segments preferably has a number average molecular weight in the range of about 1,000 to about 3,000. The polyalkylene ether glycol having the relatively longer alkyleneoxy segments has a number average molecular weight of at least about 800, and the molecular weight can be as high as about 4,000. Preferably the polyalkylene ether glycols that constitute the admixture have substantially the same number average molecular weight, more preferably a number average molecular weight of about 2,000. It is also preferable that the polyalkylene ether glycol having the relatively shorter alkyleneoxy segments constitutes at least about 10 mole percent of the admixture, and the polyalkylene ether glycol having the relatively longer alkyleneoxy segments constitutes a major portion of the admixture, i.e., more than about 50 mole percent of the glycol admixture. Particularly preferred are polyalkylene ether glycol admixtures containing about 25 mole percent of the glycol having the relatively shorter alkyleneoxy segments and about 75 mole percent of the glycol having the relatively longer alkyleneoxy segments. Illustrative of the polyalkylene ether glycol admixtures useful in the formation of the prepolymer are polyethylene glycol with polytetramethylene glycol, polypropylene glycol with 1,2-polydimethylethylene glycol, polydecamethylene glycol with polyethylene glycol, and the like. A preferred polyalkylene ether glycol admixture is that of polytetramethylene glycol and polyethylene glycol. For films suitable for use in wound dressings, a preferred combination is polytetramethylene glycol (PTMEG) having a number average molecular weight of about 2,000 and polyethylene glycol (PEG) having a number average molecular weight of about 2,000 in a mole ratio of about 1:1 to about 3:1, respectively, for an optimum degree of hydrophilicity in combination with a desired degree of hydrogen bonding in the produced film.
The formation of the isocyanate terminated prepolymer occurs in a liquid state and at a temperature of about 50 to about 100°C, preferably at about 80 to about 85°C. The reaction time is about 1 to about 1-1/2 hours. Although it is preferred that this reaction take place in a melt, it may equally well be carried out in solution using a suitable solvent such as dimethylacetamide (DMAC) , dimethylformamide (DMF), tetrahydrofuran (THF), or the like. The preferred solvent is DMAC. If the reaction takes place in the melt, the prepolymer is then dissolved in the aforementioned solvent.
When dissolution is complete, the prepolymer is chain extended to the desired number average molecular weight, usually in the range of about 20,000 to about 260,000, using a difunctional chain extender, preferably an admixture of such chain extenders. In the chain extender admixture at least one chain extender is an aliphatic diamine and at least one other chain extender is an alkanolamine.
Suitable aliphatic diamine chain extenders include ethylene diamine, m-xylylene diamine, propylene diamine, and the like. Suitable alkanolamine chain extenders include ethanolamine, and the like. Other chain extenders such as diols can also be present. A preferred combination of chain extenders is ethylene diamine with ethanolamine. The mol ratio of ethylene diamine to ethanolamine can be about 0.25:0.75 to about 0.75:0.25.
A preferred monofunctional amine chain control agent includes at least one member of the group consisting of 3,3-dimethylbutylamine, dimethylcyclohexylamine, 1,5-dimethylhexylamine, and dimethylethylene diamine. The amount of the chain control agent is dependent on the amount of NCO-groups present in the prepolymer and the desired chain extension. In any particular case, sufficient chain control agent is added to react with the remaining NCO-groups present after the desired degree of chain extension has been achieved.
The chain extender and chain control agent are dissolved in a suitable solvent such as DMAC, DMF, THF, etc. as mentioned hereinabove.
The prepolymer is then reacted with the chain extender and chain control agent solution to obtain the desired chain extension of the prepolymer. This reaction is usually carried out at a temperature of about 80 to about 85°C. over a time period of about 2 to about 3-1/2 hours. A polyurethane-urea resin solution is thus produced. Optionally, the hydrophilicity of the polyurethane resin may be enhanced by the use of an extrinsic wetting agent such as polyvinylpyrrolidone or the like, which is added to the polymerized resin prior to film forming. The amount of polyvinylpyrrolidone utilized for this purpose is about 1 to about 50 percent by weight of the composition.
The following examples illustrate typical preparations of polyurethane-ureas embodying the present invention. In these examples, the polyurethane-urea prepolymer was prepared in a suitable reactor vessel equipped with an agitator, a temperature sensor, a temperature control and a nitrogen source and bleed. The chain extenders and chain control agents were admixed in a separate mixing vessel and the resulting admixture was then added to the reactor vessel. EXAMPLE 1
Polytetramethylene glycol (M.W. 1000; 257.14 grams) and polyethylene glycol (M.W. 1000; 28.57 grams) were combined and melted at a temperature of approximately 40 to 45°C. in the reactor under a nitrogen blanket. 4,4'-Diphenylmethane diisocyanate (117.86 grams) was added to the reactor under agitation. The resulting mixture was stirred, heated to a temperature of about 60 to 65°C. and maintained within this temperature range for a time period of about 1 to about 1-1/2 hours to produce a molten prepolymer. Dry dimethylacetamide (DMAC; 857.59 grams) was then added to the molten prepolymer and the admixture was stirred until dissolution of the prepolymer was complete. This occurred in about 15 to about 30 minutes.
Dry DMAC (350.0 grams), ethanolamine (4.68 grams), ethylene diamine (4.60 grams) and dimethylethylene diamine (0.88 grams) were combined in a separate vessel, mixed at room temperature, and then added rapidly to the prepolymer solution with vigorous agitation. Thereafter, the prepolymer solution containing these additives was maintained at a temperature of approximately 80 to 85 °C. for a time period of about 2 to about 3-1/2 hours.
The resultant polyurethane resin solution was colorless and viscous, and was cast into a visually clear film. EXAMPLE 2
Polytetramethylene glycol (M.W. 1000; 214.29 grams) and polyethylene glycol (M.W. 1000; 71.43 grams) were combined and melted at a temperature of approximately 40 to 45°C. in the reactor under a nitrogen blanket. 4,4'-Diphenylmethane diisocyanate (117.86 grams) was added to the reactor under agitation. The resulting mixture was stirred, heated to a temperature of about 60 to 65°C. and maintained within this temperature range for a time period of about 1 to about 1-1/2 hours. Dry dimethylacetamide (DMAC; 857.59 grams) was then added to the molten prepolymer and the admixture was stirred until dissolution of the prepolymer was complete. This occurred in about 15 to about 30 minutes. Dry DMAC (350.0 grams), ethanolamine (4.86 grams), ethylene diamine (4.77 grams) and dimethylethylene diamine (0.92 grams) were combined together in a separate vessel, mixed at room temperature, and then added rapidly to the prepolymer solution with vigorous agitation. Thereafter, the prepolymer solution containing the additives was maintained at a temperature of approximately 80 to 85°C. for a time period of about 2 to about 3-1/2 hours. The resultant polyurethane resin solution was colorless and viscous, and was cast into a visually clear film. EXAMPLE 3 Polytetramethylene glycol (M.W. 1000; 142.86 grams) and polyethylene glycol (M.W. 1000; 142.86 grams) were combined and melted at a temperature of approximately 40 to 45°C. in the reactor under a nitrogen blanket. 4,4'-Diphenylmethane diisocyanate (117.86 grams) was added to the reactor under agitation. The resulting mixture was stirred, heated to a temperature of about 60 to 65°C. and maintained within this temperature range for a time period of about 1 to about 1-1/2 hours to produce a molten prepolymer. Dry dimethylace.tamide (DMAC; 857.59 grams) was then added to the molten prepolymer and the admixture was stirred until dissolution of the prepolymer was complete. This occurred in about 15 to about 30 minutes. Dry DMAC (350.0 grams), ethanolamine (4.47 grams), ethylene diamine (4.49 grams) and dimethylethylene diamine (0.84 grams) were combined together in a separate vessel, mixed at room temperature, and then added rapidly to the prepolymer solution with vigorous agitation. Thereafter, the prepolymer solution containing these additives was maintained at a temperature of approximately 80 to 85°C. for a time period of about 2 to about 3-1/2 hours. The resultant polyurethane resin solution was colorless and viscous, and was cast into a visually clear film. EXAMPLE 4
Polytetramethylene glycol (M.W. 1000; 71.43 grams) and polyethylene glycol (M.W. 1000; 214.29 grams) were combined and melted at approximately 40 to 45°C. in the reactor under a nitrogen blanket. 4,4'-Diphenylmethane diisocyanate (117.86 grams) was added to the reactor under agitation. The resulting mixture was stirred, heated to a temperature of about 60 to 65°C. and maintained within this temperature range for a time period of about 1 to about 1-1/2 hours to produce a molten prepolymer. Dry dimethylacetamide (DMAC; 857.61 grams) was then added to the molten prepolymer and the admixture was stirred until dissolution of the prepolymer was complete. This occurred in about 15 to about 30 minutes.
Dry DMAC (350.0 grams), ethanolamine (4.34 grams), ethylene diamine (4.27 grams) and dimethylethylene diamine (0.82 grams) were combined in a separate vessel, mixed at room temperature, and then added rapidly to the prepolymer solution with vigorous agitation. Thereafter, the prepolymer solution containing these additives was maintained at a temperature of approximately 80 to 85°C. for a time period of about 2 to about 3-1/2 hours.
The resultant polyurethane resin solution was colorless and viscous, and was cast into a visually clear film.
In a manner similar to that of the foregoing examples, additional polyurethane-ureas embodying this invention were prepared and the physical properties thereof noted. The amounts of reactants used and the properties noted are set forth in the Tables hereinbelow. TABLE I COMPOSITION AMD PHYSICAL CHARACTERISTICS OF THE PREPOLYMER
MOLE
MWT MWT CHAIN VISCOSITY FRACTION
SAMPLE %PEG1 PEG2 PΉΈG3 EXTENSION4 %NOD5 (CPS) EDA
001 75 1000 1000 40 1.090 3400 0.25
002 50 1000 1000 10 1.050 390 0.25
003 25 1000 1000 20 1.070 2460 0.25
004 75 1000 1000 10 1.020 900 0.75
005 25 1000 1000 40 1.070 14480 0.75
006 50 1000 1000 20 1.040 5010 0.75
007 75 1000 1000 20 0.980 3060 0.50
008 50 1000 1000 40 1.040 13680 0.50
009 25 1000 1000 10 1.050 2160 0.50
010 25 1000 650 20 1.300 2810 0.50
011 50 1000 650 10 1.190 890 0.50
012 75 1000 650 40 1.080 16840 0.50
013 75 1000 650 10 1.090 630 0.25
014 25 1000 650 40 1.280 11320 0.75
015 50 1000 650 20 1.190 2610 0.25
016 50 1000 650 40 1.220 3970 0.50
017 25 1000 650 40 1.340 5100 0.25
018 25 1000 650 10 1.340 1590 0.75
019 50 1000 650 40 1.190 9640 0.75
020 75 1000 650 20 1.120 1240 0.75
021 50 1000 2000 20 0.820 1450 0.50
022 25 1000 2000 40 0.780 8220 0.50
023 75 1000 2000 10 0.910 790 0.50
024 75 1000 2000 40 0.930 1600 0.75
025 50 1000 2000 10 0.860 6300 0.75
026 25 1000 2000 10 0.740 1880 0.25
027 50 1000 1000 20 1.060 3560 0.50
028 25 1000 2000 20 0.920 1320 0.75
029 50 1000 1000 20 1.060 1530 0.50
030 75 1000 2000 20 0.790 4350 0.25 031 50 1000 1000 20 0.900 1410 0.50
032 50 1000 2000 40 0.800 10060 0.25
033 50 1000 1000 20 1.070 2860 0.50
034 25 600 650 10 1.420 690 0.25
035 50 600 1000 10 1.110 7000 0.50
036 75 600 2000 10 0.900 1780 0.75
037 50 600 650 40 1.260 2770 0.25
038 25 600 1000 20 1.150 4590 0.50
039 75 600 1000 40 1.110 7440 0.50
040 50 600 2000 20 0.850 7540 0.75
041 25 600 2000 40 0.760 23700 0.75
042 25 600 1000 40 1.190 11440 0.25
043 75 600 650 20 1.310 1180 0.25
044 50 600 2000 40 0.820 6300 0.50
045 50 600 1000 40 1.170 4940 0.75
046 50 600 1000 20 1.130 3900 0.25
047 75 600 1000 10 1.120 2990 0.25
048 75 600 1000 20 1.540 5610 0.75
049 25 600 1000 10 1.130 2130 0.75
050 50 600 2000 10 0.880 1640 0.25
051 75 600 2000 40 1.010 5090 0.25
052 25 600 2000 20 0.720 5790 0.25
053 25 600 2000 10 0.750 4050 0.50
054 75 600 2000 20 0.950 2780 0.50
055 75 600 650 40 1.070 7510 0.75
056 25 600 650 10 1.370 1690 0.75
057 50 600 650 10 1.270 1480 0.75
058 50 600 650 20 1.310 2300 0.50
059 75 600 650 10 1.220 620 0.50
Mole percent of polyethylene glycol present based on the polyalkylene glycols present in the composition. 2
Number average molecular weight of the polyethylene glycol. 3
Number average molecular weight of the polytetramethylene glycol. 4 Number of folds by which the prepolymer was chain extended.
Percent NOD-groups in the prepolymer. TABLE II
PHYSICAL PROPERTIES
DRT PROPERTIES1 WET PROPERTIES1 MDISTURE VA POR TRANSPORT RATE (g/m2 /24 hrs)
TENSILE TENSILE
STRENGTH PERCENT STRENGTH PERCENT
SAMPLE (kg/mm2) ELONGATION (kg/mm2) ELONGATION INVERTED CUP2 _NON-INVERTED CUP3 WATER ABSORPTION(%)
001 0.43 1035 0.45 764 9744 3312 67.4
002 0.28 200 0.26 152 5736 1080 42.4
003 1.67 1000 1.65 902 1344 1056 15.4
004 0.69 475 0.36 210 13896 2568 66.0
005 5.30 875 4.81 855 1032 1032 12.2
006 3.10 1090 1.92 750 4272 1584 31.4
007 0.55 890 0.57 726 17700 2568 69.3
008 5.28 775 6.70 793 2280 888 3.8
009 2.38 745 3.40 782 2496 816 3.7
010 2.02 650 1.09 400 3000 816 20.9
011 0.51 480 0.69 634 5448 1464 40.0
012 1.75 1300 1.51 948 12168 2664 64.6
013 0.11 180 0.08 91 19152 2448 77.5
014 6.10 775 3.43 693 912 768 17.0
015 0.70 1040 0.52 574 5112 1536 43.3
016 1.78 995 0.32 826 4584 1608 38.2
017 3.95 830 1.77 694 984 864 21.0
018 1.75 620 1.66 673 936 816 20.0
019 3.92 900 3.97 850 3888 1728 36.6
020 0.77 625 0.93 632 13428 2568 58.3
021 0.93 860 1.52 850 5304 1752 34.5
022 3.33 1015 3.67 941 1968 1056 10.2
023 0.35 575 0.62 681 9144 2280 55.2
024 1.52 950 1.74 853 7512 1416 25.4
025 2.19 1005 1.99 838 9696 2088 49.0
026 1.80 1250 2.11 1109 1344 1800 8.4
027 1.35 1075 1.61 883 6504 1392 35.5
028 2.25 785 2.11 687 1296 1248 11.6
029 0.78 895 0.81 742 4176 1560 38.2
Figure imgf000023_0001
TABLE III
TENSILE STRENGTH AT BREAK (kg/mm2)
SAMPLE DRY WET DIFFERENCE1 PERCENT CHANGE
001 0.43 0.45 -0.02 -4.65
002 0.28 0.26 0.02 7.14
003 1.67 1.65 0.02 1.20
004 0.69 0.36 0.33 47.83
005 5.30 4.81 0.49 9.25
006 3.10 1.92 1.18 38.06
007 0.55 0.57 -0.02 -3.64
008 5.28 6.70 -1.42 -26.89
009 2.38 3.40 -1.02 -42.86
010 2.02 1.09 0.93 46.04
011 0.51 0.69 -0.18 -35.29
012 1.75 1.51 0.24 13.71
013 0.11 0.08 0.03 27.27
014 6.10 3.43 2.67 43.77
015 0.70 0.52 0.18 25.71
016 1.78 0.32 1.46 82.02
017 3.95 1.77 2.18 55.19
018 1.75 1.66 0.09 5.14
019 3.92 3.97 -0.05 -1.28
020 0.77 0.93 -0.16 -20.78
021 0.93 1.52 -0.59 -63.44
022 3.33 3.67 -0.34 -10.21
023 0.35 0.62 -0.27 -77.14
024 1.52 1.74 -0.22 -14.47
025 2.19 1.99 0.20 9.13
026 1.80 2.11 -0.31 -17.22
027 1.35 1.61 -0.26 -19.26
028 2.25 2.11 0.14 6.22
029 0.78 0.81 -0.03 -3.85
030 0.80 2.54 -1.74 -217.50
031 1.49 1.47 0.02 1.34
032 3.93 3.67 0.26 6.62
033 1.28 1.32 -0.04 -3.13 034 2.54 0.56 1.98 77.95
035 1.32 0.76 0.56 42.42
036 2.57 2.28 0.29 11.28
037 7.40 2.60 4.80 64.86
038 4.35 3.61 0.74 17.01
039 6.94 1.33 5.61 80.84
040 5.20 4.43 0.77 14.81
041 5.44 4.50 0.94 17.28
042 5.61 4.74 0.87 15.51
043 1.56 0.44 1.12 71.79
044 3.73 4.27 0.54 14.48
045 4.00 2.58 1.42 35.50
046 3.60 2.25 1.35 37.50
047 1.83 1.00 0.83 45.36
048 6.49 3.47 3.02 46.53
049 2.69 3.43 -0.74 -27.51
050 2.40 1.30 1.10 45.83
051 2.51 1.64 0.87 34.66
052 2.58 3.53 -0.95 -36.82
053 2.49 2.91 -0.42 -16.87
054 2.87 2.13 0.74 25.78
055 6.45 2.29 4.16 64.50
056 4.38 2.96 1.42 32.42
057 4.04 1.51 2.53 62.62
058 4.13 1.74 2.39 57.87
059 0.00 0.46 -0.46 0.00
Difference = Dry - Wet
Figure imgf000025_0001
numbers indicate a decrease in tensile strength after wetting with water; negative numbers indicate an increase in tensile strength after wetting with water. TABLE IV
PERCENT ELONGATION AT BREAK
SAMPLE DRY WET DIFFERENCE1 PERCENT CHANGE2
001 1035.0 764.0 271.0 26.2
002 200.0 152.0 48.0 24.0
003 1000.0 902.0 98.0 9.8
004 475.0 210.0 265.0 55.8
005 875.0 855.0 20.0 2.3
006 1090.0 750.0 340.0 31.2
007 890.0 726.0 164.0 18.4
008 775.0 793.0 -18.0 -2.3
009 745.0 782.0 -37.0 -5.0
010 650.0 400.0 250.0 38.5
011 480.0 634.0 -154.0 -32.1
012 1300.0 948.0 352;0 27.1
013 180.0 91.0 89.0 49.4
014 775.0 693.0 82.0 10.6
015 1040.0 574.0 466.0 44.8
016 995.0 826.0 169.0 17.0
017 830.0 694.0 136.0 16.4
018 620.0 673.0 -53.0 -8.5
019 900.0 850.0 50.0 5.6
020 625.0 632.0 -7.0 -1.1
021 860.0 850.0 10.0 1.2
022 1015.0 941.0 74.0 7.3
023 575.0 681.0 -106.0 -18.4
024 950.0 853.0 97.0 10.2
025 1005.0 838.0 167.0 16.6
026 1250.0 1109.0 141.0 11.3
027 1075.0 883.0 192.0 17.9
028 785.0 687.0 98.0 12.5
029 895.0 742.0 153.0 17.1
030 2370.0 1390.0 980.0 41.4
031 1162.0 1021.0 141.0 12.1
032 1100.0 1057.0 43.0 3.9
033 985.0 875.0 110.0 11.2 034 630.0 266.0 364.0 57.8
035 830.0 559.0 271.0 32.7
036 874.0 771.0 103.0 11.8
037 690.0 711.0 -21.0 -3.0
038 795.0 690.0 105.0 13.2
039 875.0 562.0 313.0 35.8
040 910.0 818.0 92.0 10.1
041 885.0 801.0 84.0 9.5
042 835.0 828.0 7.0 0.8
043 710.0 234.0 476.0 67.0
044 910.0 945.0 -35.0 -3.8
045 720.0 697.0 23.0 3.2
046 925.0 832.0 93.0 10.1
047 1175.0 868.0 307.0 26.1
048 670.0 591.0 79.0 11.8
049 815.0 786.0 29.0 3.6
050 1034.0 831.0 203.0 19.6
051 1260.0 881.0 379.0 30.1
052 1215.0 1124.0 91.0 7.5
053 1045.0 930.0 107.0 10.2
054 945.0 821.0 124.0 13.1
055 725.0 683.0 42.0 5.8
056 605.0 673.0 -68.0 -11.2
057 670.0 588.0 82.0 12.2
058 655.0 652.0 3.0 0.5
059 0.0 236.0 -236.0 0.0
Difference = Dry - Wet
Figure imgf000027_0001
positive numbers indicate a decrease in percent elongation after wetting with water; negative numbers indicate an increase in percent elongation after wetting with water. The polyurethane resins of the present invention are particularly well suited for the manufacture of components for wound dressings and closures inasmuch as the high level of hydrophilicity, and therefore the absorption capacity, inherent in these polymers are important properties in this regard. Environmental wound dressings rely upon being able to absorb wound exudate while maintaining a moist microenvironment at the wound site to obtain optimum healing.
Wounds or injuries to the skin generate varying amounts of discharge fluid known as exudate. Modern wound care management techniques seek to maintain the moisture level at the wound site at a relatively high level. But, excessive build up of exudate is unacceptable. The present polyurethane resins can be tailored to have properties, when cast into films, so as to absorb excess exudate while maintaining a high level of moisture at the wound site.
In addition, the chemical, physical and mechanical properties of the present polyurethanes allow their use in a wide variety of other applications. The material's wet strength properties and selective permeability towards water vapor and other gases are particularly significant in this regard.
The present polymers may be coated onto textile substrates to provide breathability while retaining resistance to liquids, particularly water. In a similar fashion, selectively permeable films may be fabricated for use as containers for desiccants and other absorbent agents (e.g., crystalline aluminosilicates, silica gel, etc.). The use of these films in this application has the advantage of preventing particulate contamination of the article into which the desiccant package will be placed and reduction of efficiency due to nonspecific absorption. Films of these materials are also suitable for packaging. Their selective gaseous and moisture vapor transmission properties allow their application in the area of environmental packaging.
These polymers are biocompatible and noncytotoxic which makes them ideal for medical and biological applications. These properties enable the present polymers to be used as substrates for the support, growth and attachment of biological materials. They are of particular utility in the area of cell growth substrates for mammalian cell culture. The attachment and growth of cells to structures manufactured from these polymers makes them ideal for use in bioreactor systems for large scale production of cell lines, etc. Immobilization of proteins, enzymes and other biologically active materials, while maintaining biological activity, allows the use of these polymers as active structures in biosensors and diagnostic test kits. Similarly, nonbiologically active catalysts may be incorporated in these polymers, thereby facilitating their use in numerous chemical and physical processes.
Selective transport of chemical agents through polymer films fabricated from these polymers can be used in the areas of filtration, separation and purification of liquids and gases. These properties are also of use in the area of drug delivery over an extended time period where therapeutic agents are delivered from a reservoir across a polymer membrane into the physiological environment. It is also envisaged that these polymers may be used as specialty coatings to inhibit corrosion of metallic surfaces while facilitating selective gaseous transport. The present segmented polyether polyurethane resins are also useful for the fabrication of vascular grafts, ureters and other biocompatible elements.
This invention has been described in terms of specific embodiments set forth in detail, but it should be understood that these are by way of illustration only and that the invention is not necessarily limited thereto. Modifications and variations will be apparent from this disclosure and may be resorted to without departing from the spirit of this invention, as those skilled in the art will readily understand. Accordingly, such variations and modifications of the disclosed products are considered to be within the purview and scope of this invention and the following claims.

Claims

WE CLAIM:
1. A hydrophilic but water-insoluble, segmented polyether polyurethane-urea having a wet strength greater than dry strength and capable of forming a visually clear film; said polyurethane-urea being the reaction product of a prepolymer derived from a stoichiometric excess of a diisocyanate reacted with an admixture of polyalkylene ether glycols each having different-length alkyleneoxy segments, and extended with a difunctional amine chain extender.
2. The segmented polyether polyurethane-urea of claim 1 wherein said admixture of polyalkylene ether glycols is constituted by polytetramethylene glycol and polyethylene glycol.
3. The segmented polyether polyurethane-urea of claim 2 wherein polytetramethylene glycol and polyethylene glycol are present in the admixture in a mole ratio of about 3:1.
4. The segmented polyether polyurethane-urea of claim 1 wherein said relatively shorter segment glycol have a molecular weight in the range of about 1000 to about 3,000 and said relatively longer segment glycol has molecular weight of at least about 800.
5. The segmented polyether polyurethane-urea of claim 1 wherein said glycols have a number average molecular weight of about 2000.
6. The segmented polyether polyurethane-urea of claim 1 wherein said glycols have substantially the same number average molecular weight.
7. The segmented polyether polyurethane-urea of claim 6 wherein the polyalkylene ether glycol having the relatively shorter alkyleneoxy segments constitutes at least about 10 mole percent of the admixture and the polyalkylene ether glycol having the relatively longer alkyleneoxy segments constitutes more than about 50 mole percent of the admixture.
8. The segmented polyether polyurethane-urea of claim 1 wherein the polyalkylene ether glycol having the relatively longer alkyleneoxy segments and the polyalkylene ether glycol having the relatively shorter alkyleneoxy segments are present in a mole ratio of about 3:1, respectively.
9. The segmented polyether polyurethane-urea of claim 8 wherein both of said glycols have substantially the same number average molecular weight.
10. The segmented polyether polyurethane-urea of claim 9 wherein said glycols have a number average molecular weight of about 2,000.
PCT/US1989/002618 1988-06-17 1989-06-15 Segmented polyether polyurethane WO1989012653A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP1507147A JP3065629B2 (en) 1988-06-17 1989-06-15 Method for producing segmented polyether polyurethane urea
FI900800A FI900800A0 (en) 1988-06-17 1990-02-16 SEGMENTERAD POLYETERPOLYURETAN.
NO90900764A NO900764L (en) 1988-06-17 1990-02-16 SEGMENTED POLYETHER POLYURETHAN.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/208,153 US4849458A (en) 1988-06-17 1988-06-17 Segmented polyether polyurethane
US208,153 1988-06-17

Publications (1)

Publication Number Publication Date
WO1989012653A1 true WO1989012653A1 (en) 1989-12-28

Family

ID=22773398

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1989/002618 WO1989012653A1 (en) 1988-06-17 1989-06-15 Segmented polyether polyurethane

Country Status (13)

Country Link
US (1) US4849458A (en)
EP (1) EP0348105B1 (en)
JP (1) JP3065629B2 (en)
AT (1) ATE94178T1 (en)
AU (1) AU616288B2 (en)
CA (1) CA1331062C (en)
DE (1) DE68908968T2 (en)
ES (1) ES2058528T3 (en)
FI (1) FI900800A0 (en)
IL (1) IL90609A0 (en)
NZ (1) NZ229578A (en)
WO (1) WO1989012653A1 (en)
ZA (1) ZA894494B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0962227A1 (en) * 1998-06-02 1999-12-08 Terumo Kabushiki Kaisha Indwelling catheter

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4033893A (en) * 1992-04-24 1993-11-29 Polymer Technology Group, Inc., The Copolymers and non-porous, semi-permeable membrane thereof and its use for permeating molecules of predetermined molecular weight range
US5308389A (en) * 1992-05-05 1994-05-03 Pennzoil Products Company Metal appearance composition
US5208313A (en) * 1992-07-16 1993-05-04 Surface Coatings, Inc. Waterproof breathable polyurethane membranes and porous substrates protected therewith
GB9306887D0 (en) * 1993-04-01 1993-05-26 Graham Neil B Random block copolymers
DE4428458A1 (en) 1994-08-11 1996-02-15 Bayer Ag Cycloaliphatic thermoplastic polyurethane elastomers
US5653699A (en) * 1994-09-13 1997-08-05 Polymedica Industries, Inc. Spyrosorbent wound dressings for exudate management
AUPO251096A0 (en) 1996-09-23 1996-10-17 Cardiac Crc Nominees Pty Limited Polysiloxane-containing polyurethane elastomeric compositions
WO1998012274A1 (en) * 1996-09-23 1998-03-26 Chandrashekar Pathak Methods and devices for preparing protein concentrates
US20050033132A1 (en) * 1997-03-04 2005-02-10 Shults Mark C. Analyte measuring device
US5958704A (en) 1997-03-12 1999-09-28 Ddx, Inc. Sensing system for specific substance and molecule detection
US5962018A (en) * 1998-04-28 1999-10-05 Avon Products, Inc. Method of treating the skin with organic acids in anhydrous microsphere delivery systems
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6824820B1 (en) 1999-06-07 2004-11-30 3M Innovative Properties Company Polyurea-based adhesives, articles therefrom and methods of their preparation and use
US6566575B1 (en) 2000-02-15 2003-05-20 3M Innovative Properties Company Patterned absorbent article for wound dressing
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US7041468B2 (en) 2001-04-02 2006-05-09 Therasense, Inc. Blood glucose tracking apparatus and methods
US9282925B2 (en) 2002-02-12 2016-03-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8364229B2 (en) 2003-07-25 2013-01-29 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7613491B2 (en) 2002-05-22 2009-11-03 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US7005143B2 (en) * 2002-04-12 2006-02-28 3M Innovative Properties Company Gel materials, medical articles, and methods
US7226978B2 (en) 2002-05-22 2007-06-05 Dexcom, Inc. Techniques to improve polyurethane membranes for implantable glucose sensors
US20040116594A1 (en) * 2002-12-11 2004-06-17 Debkumar Bhattacharjee Polyurethane prepolymer, stable aqueous dispersions with high solids containing the same and method of using and preparing the aqueous dispersions
US7612248B2 (en) * 2002-12-19 2009-11-03 3M Innovative Properties Company Absorbent medical articles
US7875293B2 (en) 2003-05-21 2011-01-25 Dexcom, Inc. Biointerface membranes incorporating bioactive agents
EP1648298A4 (en) 2003-07-25 2010-01-13 Dexcom Inc Oxygen enhancing membrane systems for implantable devices
US7761130B2 (en) 2003-07-25 2010-07-20 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8423113B2 (en) 2003-07-25 2013-04-16 Dexcom, Inc. Systems and methods for processing sensor data
US9763609B2 (en) 2003-07-25 2017-09-19 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US8761856B2 (en) 2003-08-01 2014-06-24 Dexcom, Inc. System and methods for processing analyte sensor data
US8160669B2 (en) 2003-08-01 2012-04-17 Dexcom, Inc. Transcutaneous analyte sensor
US20100168543A1 (en) 2003-08-01 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US7494465B2 (en) 2004-07-13 2009-02-24 Dexcom, Inc. Transcutaneous analyte sensor
US8369919B2 (en) 2003-08-01 2013-02-05 Dexcom, Inc. Systems and methods for processing sensor data
US8060173B2 (en) 2003-08-01 2011-11-15 Dexcom, Inc. System and methods for processing analyte sensor data
US20140121989A1 (en) 2003-08-22 2014-05-01 Dexcom, Inc. Systems and methods for processing analyte sensor data
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20050070688A1 (en) * 2003-09-26 2005-03-31 3M Innovative Properties Company Reactive hydrophilic oligomers
WO2005051170A2 (en) 2003-11-19 2005-06-09 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US8364231B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8774886B2 (en) 2006-10-04 2014-07-08 Dexcom, Inc. Analyte sensor
EP2239567B1 (en) 2003-12-05 2015-09-02 DexCom, Inc. Calibration techniques for a continuous analyte sensor
EP2329763B1 (en) 2003-12-09 2017-06-21 DexCom, Inc. Signal processing for continuous analyte sensor
US7384984B2 (en) * 2003-12-10 2008-06-10 3M Innovative Properties Company Reactive hydrophilic oligomers
US7637868B2 (en) 2004-01-12 2009-12-29 Dexcom, Inc. Composite material for implantable device
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US7074839B2 (en) * 2004-03-01 2006-07-11 3M Innovative Properties Company Crosslinkable hydrophilic materials from reactive oligomers having pendent photoinitiator groups
US7342047B2 (en) * 2004-03-02 2008-03-11 3M Innovative Properties Company Crosslinkable hydrophilic materials from reactive oligomers having pendent unsaturated groups
US20050249791A1 (en) * 2004-05-07 2005-11-10 3M Innovative Properties Company Antimicrobial articles
US7310544B2 (en) 2004-07-13 2007-12-18 Dexcom, Inc. Methods and systems for inserting a transcutaneous analyte sensor
US7857760B2 (en) 2004-07-13 2010-12-28 Dexcom, Inc. Analyte sensor
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US20060270922A1 (en) 2004-07-13 2006-11-30 Brauker James H Analyte sensor
US7230043B2 (en) * 2004-09-07 2007-06-12 3M Innovative Properties Company Hydrophilic polymer composition
GB0500764D0 (en) 2005-01-14 2005-02-23 Baxenden Chem Low swell, water vapour permeable poly(urethane-urea)s
US8609131B2 (en) * 2005-01-25 2013-12-17 3M Innovative Properties Company Absorbent dressing comprising hydrophilic polymer prepared via Michael reaction
US7335690B2 (en) * 2005-01-25 2008-02-26 3M Innovative Properties Company Crosslinkable hydrophilic materials from polymers having pendent Michael donor groups
EP1991110B1 (en) 2006-03-09 2018-11-07 DexCom, Inc. Systems and methods for processing analyte sensor data
WO2007120381A2 (en) 2006-04-14 2007-10-25 Dexcom, Inc. Analyte sensor
US7981949B2 (en) * 2006-05-23 2011-07-19 3M Innovative Properties Company Curable hydrophilic compositions
US20080071158A1 (en) 2006-06-07 2008-03-20 Abbott Diabetes Care, Inc. Analyte monitoring system and method
US20200037875A1 (en) 2007-05-18 2020-02-06 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
EP2152350A4 (en) 2007-06-08 2013-03-27 Dexcom Inc Integrated medicament delivery device for use with continuous analyte sensor
EP2227132B1 (en) 2007-10-09 2023-03-08 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
EP2108387A1 (en) * 2008-04-08 2009-10-14 Bayer MaterialScience AG Aqueous non-ionic polyurethane dispersions containing silver
WO2010111660A1 (en) 2009-03-27 2010-09-30 Dexcom, Inc. Methods and systems for promoting glucose management
WO2012142502A2 (en) 2011-04-15 2012-10-18 Dexcom Inc. Advanced analyte sensor calibration and error detection
IN2014DN10819A (en) * 2012-06-08 2015-09-04 Poly Med Inc
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
CA3077720A1 (en) 2017-10-24 2019-05-02 Dexcom, Inc. Pre-connected analyte sensors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963681A (en) * 1973-07-03 1976-06-15 Bridgestone Tire Company Limited Urethane elastomers prepared from polyethers having a certain molecular weight distribution

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4949040A (en) * 1972-09-18 1974-05-13
US4686137A (en) * 1980-02-29 1987-08-11 Thoratec Laboratories Corp. Moisture vapor permeable materials
JPS6015335B2 (en) * 1981-09-02 1985-04-18 東洋紡績株式会社 blood handling equipment
US4532316A (en) * 1984-05-29 1985-07-30 W. L. Gore & Assoc., Inc. Phase separating polyurethane prepolymers and elastomers prepared by reacting a polyol having a molecular weight of 600-3500 and isocyanate and a low molecular weight chain extender in which the ratios of reactants have a limited range
JPS61200114A (en) * 1985-02-28 1986-09-04 Nippon Zeon Co Ltd Antithrombotic polyurethane compound and production thereof
WO1988000214A1 (en) * 1986-06-26 1988-01-14 Tyndale Plains-Hunter, Ltd. Polyurethane polymers prepared from mixed alkylene glycol resins
GB8719314D0 (en) * 1987-08-14 1987-09-23 Smith & Nephew Ass Hypoadherant dressings
US4870150A (en) * 1988-05-23 1989-09-26 Tremco Incorporated Polyurethanes made from blends of polypropyleneoxide polyol and polybutyleneoxide polyol intermediates

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963681A (en) * 1973-07-03 1976-06-15 Bridgestone Tire Company Limited Urethane elastomers prepared from polyethers having a certain molecular weight distribution

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0962227A1 (en) * 1998-06-02 1999-12-08 Terumo Kabushiki Kaisha Indwelling catheter
US6342047B1 (en) 1998-06-02 2002-01-29 Terumo Kabushiki Kaisha Indwelling catheter

Also Published As

Publication number Publication date
JPH02504650A (en) 1990-12-27
EP0348105A2 (en) 1989-12-27
AU616288B2 (en) 1991-10-24
FI900800A0 (en) 1990-02-16
ZA894494B (en) 1990-03-28
DE68908968T2 (en) 1994-01-05
IL90609A0 (en) 1990-01-18
ATE94178T1 (en) 1993-09-15
JP3065629B2 (en) 2000-07-17
DE68908968D1 (en) 1993-10-14
NZ229578A (en) 1990-12-21
CA1331062C (en) 1994-07-26
US4849458A (en) 1989-07-18
EP0348105A3 (en) 1990-07-04
EP0348105B1 (en) 1993-09-08
ES2058528T3 (en) 1994-11-01
AU3845289A (en) 1990-01-12

Similar Documents

Publication Publication Date Title
US4849458A (en) Segmented polyether polyurethane
EP0637323B1 (en) Copolymers and non-porous, semi-permeable membrane thereof and its use for permeating molecules of predetermined molecular weight range
US4739013A (en) Polyurethanes
US4810582A (en) Hydrophilic polyurethane composition
CA1335317C (en) Fluorinated polyetherurethanes and medical devices therefrom
US4798876A (en) Hydrophilic polyurethane composition
US5296518A (en) Hydrophilic polyurethaneurea foams containing no toxic leachable additives and method to produce such foams
US6017997A (en) Waterborne polyurethane having film properties comparable to rubber
US5047495A (en) Polyurethane for flexible fuel containers
US5061777A (en) Thromboresistant polyetherurethane compounds and process for its production
US5430121A (en) Thermoplastic polyurethanes modified by siloxane block copolymers
US4621113A (en) Repeating block, oligomer-free, polyphase, thermoformable polyurethanes and method of preparation thereof
US5462536A (en) Protein nonadsorptive membranes for wound dressings
JPS58108219A (en) Manufacture of crosslinked hydrophilic foamed body
US4935480A (en) Fluorinated polyetherurethanes and medical devices therefrom
US5159050A (en) Polyurethane and medical article therefrom
KR100493339B1 (en) Thermoplastic Polyurethanes Containing Active Substances
US5795633A (en) Material composition and shaped article
JPH0228210A (en) Prepolymer composition, production and use thereof
GB2202855A (en) Hydrophilic polyurethane composition
CN116041660B (en) Ionic polyurethane with antibacterial activity and preparation method thereof
NO900764L (en) SEGMENTED POLYETHER POLYURETHAN.
KR20050111568A (en) Breathable hot-melt adhesive
JPH0431730B2 (en)
JPH01249821A (en) Poyurethane

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU FI JP NO

WWE Wipo information: entry into national phase

Ref document number: 900800

Country of ref document: FI